Form D · Retailing
QVL Pharmacy Holdings Inc
Dallas, TX · CIK 0001345686
Offering snapshot reported Mar 1, 2013 · SEC filing
- Reported sold
- $1.07M Offering amount: $3.56M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 7, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 1, 2013 | Initial | $1,072,837 | No comparison | 12 | SEC filing |
| Feb 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-192594
Source: Form D, filed Mar 1, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael J. Cataldo | Director |
| Chad Collins | Executive |
| Robert M. Hoyt | Director |
| David L. Maher | Director |
Issuer details
Industry: Retailing (See others in industry)
Address:
4141 Blue Lake Circle Suite 124
Dallas, TX, 75244
Dallas, TX, 75244